Skip to main content

Enhanced recovery care versus traditional non-ERAS care following osteotomies in developmental dysplasia of the hip in children: a retrospective case-cohort study

Abstract

Background

Enhanced recovery after surgery (ERAS) has been shown to shorten the length of hospital stay and reduce the incidence of perioperative complications in many surgical fields. However, there has been a paucity of research examining the application of ERAS in major pediatric orthopaedic surgeries. This study aims to compare the perioperative complications and length of hospital stay after osteotomies in children with developmental dysplasia of the hip (DDH) between ERAS and traditional non-ERAS group.

Methods

The ERAS group consisted of 86 patients included in the ERAS program from January 2016 to December 2017. The Control group consisted of 82 DDH patients who received osteotomies from January 2014 to December 2015. Length of hospital stay, physiological function, postoperative visual analogue scale (VAS) score, and postoperative complications were compared between the two groups.

Results

The mean duration of hospital stay was significantly reduced from 10.0 ± 3.1 in the traditional care group to 6.0 ± 0.8 days in the ERAS(P < 0.001). The average VAS score in the first 3 days was significantly lower in the ERAS group (2.9 ± 0.8) than the traditional non-ERAS group (4.0 ± 0.8) (P < 0.001). However, there was no significant difference in the frequency of break-out pain (VAS > 4) between two groups (29.5 ± 6.3 times vs.30.6 ± 6.5 times, P = 0.276). The frequency of postoperative fever was lower in the ERAS group. The frequency of urinary tract infection in both groups were not noticeable because the catheter was removed promptly after the surgery.

Conclusion

The ERAS protocol is both safe and feasible for pediatric DDH patients undergoing osteotomies, and it can shorten the length of hospital stay without increasing the risk of perioperative complications.

Peer Review reports

Background

Minimal invasive surgery (MIS), damage control theory (DCT), and enhanced recovery after surgery (ERAS) are three breakthroughs in the twenty-first century [1]. ERAS was proposed by Henrik Kehlet in the 1990s [2], and it has been widely applied in many surgical specialties for more than 20 years. The ERAS protocol is an evidence-based multidisciplinary perioperative approach, aiming to reduce the hospital stay, decrease the incidence of surgery-related complications, and promote early rehabilitation [3]. In orthopaedic surgery, ERAS was adopted in high-volume standard procedures, such as primary hip and knee replacements. There are reports that the ERAS protocol is both safe and effective in orthopaedic surgeries [4,5,6]. A meta-analysis showed that ERAS could facilitate the rapid recovery of physiological function, reduce the incidence of perioperative complications, shorten the duration of hospital stay [7].

However, there has been a paucity of literature examining the application of ERAS in major orthopaedic surgeries in children.

Developmental Dysplasia of the Hip (DDH) is a common bone and joint deformity of lower limbs in the pediatric population [8]. The incidence of DDH is 1.5 to 2.5 cases per 1000 live births [9, 10]. The DDH treatment aims to achieve concentric hip reduction and painless hip joint in the adolescence and adulthood. Pavlik harness is an effective option for children younger than 6 months with DDH [9, 11, 12]. However, if diagnosed at walking age, the treatment strategy might be complex and controversial [12, 13].

Pelvic osteotomy (PO) with or without proximal femoral osteotomy (PFO) is the mainstream surgical treatment for DDH [14]. The choice of osteotomy is mainly based on the age at the time of surgery, pathological and anatomical characteristics, severity of the dislocation, and clinical experience and preference of the surgeon. Osteotomy is the only effective method of treatment of DDH in patients older than 18 months [15]. However, it is not without complications. The most common perioperative complications include infection, hematoma, wound dehiscence and pain, leading to an extended hospital stay. Thus, establishing an ERAS protocol is urgent for major orthopaedic surgeries in children. Since DDH is the most commonly performed elective surgery in our hospital, we firstly established and implemented an ERAS protocol for DDH in 2016 [16]. Before the establishment of the ERAS protocol, the traditional care (non-ERAS) plan was implemented for DDH patients. The specific requirement for each step was not included in the traditional non-ERAS care plan.

This retrospective study aims to compare the incidences of complications and length of hospitalization after osteotomies in children with DDH between the ERAS group and the traditional non-ERAS group. To our knowledge, this is the first study to evaluate the effectiveness of an ERAS protocol for DDH osteotomies in children.

Methods

ERAS program

Based on the ERAS protocol adopted in the pediatric surgery and orthopaedics department, an ERAS protocol for pediatric orthopaedic surgery was developed following a series of discussions with experts from pediatric orthopaedic surgery, anesthesiology, pediatrics, and nurses from both the ward and operating room (OR). The protocol was then implemented for DDH patients undergoing surgical treatment from January 1, 2016.

The ERAS protocol for DDH osteotomies surgery included the following elements (Tables 1 and 2): preoperative education and counselling, antimicrobial prophylaxis, multimodal analgesia, postoperative nausea and vomiting (PONV) prophylaxis, early oral food intake, less daily intravenous infusion volume, early removal of wound drainage and urinary catheters, early mobilization, and discharge criteria. Preoperative education and counselling included the aim and procedures of the ERAS protocol, pain coping strategies, the parental expectation of this surgery, discharge criteria, and a follow-up plan. The fasting guideline requires cessation of clear fluid for at least 2 h as well as solid foods for 6 h before anaesthesia [17]. The temperature of the operative room was controlled at 24 degrees, and warm fluids were used. Patients were administered with multimodal analgesia postoperatively including local infiltration of ropivacaine (2.0 mg/ml) around the incision, analgesia infusion pump based on the parental requirements, intravenous nonsteroidal anti-inflammatory (flurbiprofen, 2 mg/Kg) for 3 days, and then oral dexibuprofen oral suspension if necessary. The regular diet was advised after the patient fully recovered from the anaesthesia. A lower intravenous infusion volume was defined as less than 300 ml/d after surgery. The Foleys catheter was removed within 24 h postoperatively. The drainage tube was recommended to be removed within 48 h postoperatively. Early mobilization, including the on-bed movement of the healthy leg and upper extremities on postoperative day (POD) 1. The antithrombotic prophylaxis was not necessary since children were at low risk of deep venous thrombosis (DVT). Discharge criteria were as follows: a visual analogue scale (VAS) score of < 3 points with or without the use of oral analgesia; normal diet, no need for intravenous fluid; normal body temperature, no evidence of wound infection with normal complete blood count and C-reactive protein level; and no serious complications. We encouraged patient discharge once the discharge criteria were met.

Table 1 The ERAS protocol versus traditional care
Table 2 Components of ERAS pathway for DDH

Population

The hospital medical records of DDH patients receiving unilateral osteotomies in our institution were retrospectively reviewed. We included 82 patients in the traditional non-ERAS group or control group who underwent DDH surgery just prior to the implementation of the ERAS protocol (from January 2014 to December 2015). The ERAS group consisted of 86 patients who underwent DDH surgery after the implementation of the ERAS protocol (from January 2016 to December 2017).

The inclusion criteria were: 1) Patients aged between 1.5 years and 6 years received DDH surgery (PO + PFO) after failed nonoperative management, and 2) Unilateral single-stage surgery for bilateral DDH. The exclusion criteria were: 1) Patients with prior neuromuscular disease, cerebral palsy, scoliosis and hyperlaxity, and 2) Patients over the age of 6 years.

This study is approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.

Surgical techniques

All the patients underwent PO + PFO (See Fig. 1). Pelvic osteotomy (PO) is meant for increasing the acetabular coverage on the femoral head. Acetabuloplasty offers a higher rate of correction of acetabular dysplasia in comparison with reorientation osteotomies [18].

Fig. 1
figure1

a 2 and half year-old girl received PO + PFO. a AP view of the pelvis before the surgery. b AP view of the pelvis after the surgery. c AP view of the pelvis at 3 months follow-up visit

Pemberton osteotomy has been a preferred method of pelvic osteotomy in our institution. Proximal femoral osteotomies (PFO) are designed to reorient the femoral head by derotation and increasing the varus in order to stabilize and stimulate acetabular development [19, 20]. Pediatric hip plate (PHP) system is used to fixate the osteotomy at the femoral side.

After the surgery, all patients were immobilized in Spica cast for 4–6 weeks until the first out-patient visit.

Clinical evaluation variables

Physiological function outcome indicators, such as the first time that the patient was able to eat, defecate, as well as the removal time of the Foleys catheter and drainage tubes, and duration of hospital stay were recorded.

The postoperative pain response after surgery was recorded, including the average VAS score, the highest VAS score, and the frequency of break-out pain (VAS ≥ 4). The incidence of all postoperative complications, including nausea, vomiting and fever, were recorded.

Statistical analysis

All descriptive data were presented as the mean ± SD. Statistical analysis was performed using SPSS (SPSS Inc., Chicago, IL). A p-value of < 0.05 is regarded as statistical significance.

Results

Demographic data

Demographic data are shown in Table 3. There were no significant differences in age, sex, surgical duration, intraoperative blood loss, and other comorbidities between the ERAS group and traditional non-ERAS group.

Table 3 Demographic characteristics

Clinical outcomes

The removal of Foleys and drainage tubes were significantly earlier in the ERAS group than that in the traditional non-ERAS group (Table 4). The mean duration of hospital stay was significantly reduced from 10.0 ± 3.1 in the traditional non-ERAS group to 6.0 ± 0.8 days in the ERAS(P < 0.001).

Table 4 Postoperative physiological function outcomes

The average VAS score in the first 3 days was better in the ERAS group than the traditional non-ERAS group (2.9 ± 0.8 vs. 4.0 ± 0.8, P < 0.001), and maximum VAS score (4.1 ± 0.8 vs. 4.9 ± 0.8, P < 0.001) (Table 5). However, there was no significant difference in the frequency of break-out pain (VAS > 4) between two groups (29.5 ± 6.3 vs.30.6 ± 6.5, P = 0.276).

Table 5 VAS pain score of average first 3d after surgery

Table 6 shows the surgery-related complications in both groups. There were no serious complications observed in this study. PONV was more common in the ERAS group as we used opiates as analgesics in the infusion pump. However, fever was less in the ERAS group, and no patients had postoperative urinary tract infection.

Table 6 Postoperative complications and adverse reactions

Compliance with ERAS core components

Compliance with the core components of the ERAS protocol (Table 2) is shown in Table 7. During the perioperative period, the fasting time before surgery was shortened in the ERAS group. The application of local analgesia, oral analgesia, PONV prophylaxis was well executed in the ERAS group. Because of the possible adverse reactions of opiates (Sufentanil or Oxycodone), the application of analgesia infusion pump was not well executed. In all patients, oral Dexibuprofen was given whenever necessary. Compliance of early removal of the Foleys catheter and drainage tubes in the ERAS group was 100 and 95.3% respectively. The most common cause of delayed removal of drainage catheters was high drainage volume on POD2, which may increase the risk of postoperative hematoma and local infection. Compliance with early regular diet was 95.3%.

Table 7 Compliance with ERAS core components in ERAS group

Discussion

The most important finding of the study was that the application of ERAS protocol in children undergoing osteotomies for DDH resulted in a reduced hospital stay and better pain tolerance without a significant increase in perioperative complications.

ERAS protocol has been widely applied in many surgical fields, especially in abdominal surgery. In the past few years, there were reports on its application in orthopaedic surgery such as joint replacement, trauma and spine surgery [21,22,23]. However, the literature on pediatric orthopaedic surgery was quite rare. A pediatric population is a group that requires special attention and discretion.

Preoperative evaluation of malnutrition and anaemia are critical as they are associated with a higher rate of postoperative complications such as delayed wound healing, infection, and prolonged duration of hospital stay [24, 25]. A recent history of common cold, cough, diarrhoea should be taken carefully before admission; if one had such symptoms, surgery should be postponed. A preoperative haemoglobin level of less than 12 g/dL should be investigated to rule out other pathological causes. If the bodyweight is 2 standard deviations lighter than the standard weight in peers, more attention should be paid to the patients.

Preoperative counselling and education are crucial components of the ERAS protocol. Patients and patient’s legal guardians should be counselled and educated for the expectation adjustment, pain coping mechanism, and the rehabilitation plan preoperatively. A team consisting of surgeons, nurses, physical therapists should discuss the treatment strategy with the legal guardians thoroughly. Although preoperative education reduces the level of anxiety in parents, it does not reduce the duration of hospital stay significantly, lower the VAS score and the incidence of complications [26].

Multimodal analgesia is advocated to boost the effect of pain alleviation and reduce the incidence and severity of adverse effects. One of the key aspects of the ERAS program is to reduce the dose of opiates and even eliminate the application of opioids postoperatively [27]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the cornerstone for postoperative pain alleviation, but the possible sides effects to the digestive and cardiovascular system should not be overlooked. Dexibuprofen, a non-selective NSAID, has been widely used in pediatric orthopaedics to cope with mild to moderate pain, but the long-term effects remain to be investigated. Unlike adults, most children are not able to endure pain. A novel drug such as bupivacaine liposome with longer half-life has been used in developed and used in clinical practice [28]. However, its application in children has not been thoroughly investigated. Dexamethasone is a strong anti-inflammatory drug, high dosage (> 0.1 mg/kg) is able to alleviate all kinds of postoperative pain in adults [29]. De Oliveira GS et al. performed a meta-analysis of randomized controlled trials to evaluate the dose-dependent analgesic effects of perioperative dexamethasone. They reported that an intraoperative infusion of 10 mg mg dexamethasone could reduce the duration of hospital stay significantly, and it is not associated with delayed healing and infection [30]. Dexamethasone has been used as adjuvant to Bupivacaine in the pediatric population [31, 32], but the safety and validity of the intravenous application of glucocorticoids in children for pain management remains to be investigated and rarely used in our institute.

Peripheral nerve block is routinely performed in patients with long bone fracture surgeries; however, it is not commonly performed in DDH patients. Local anaesthetic agents such as lidocaine and ropivacaine have also been reported to use around the incision site for postoperative pain management. As for joint replacement surgeries, surgeons advocate the injection of a cocktail consisting of opiates, NSAIDs, and steroids periarticularly [33]. However, this technique has not been used and validated in our institute for the pediatric population.

American Society of Anesthesiology has recommended that the preoperative fasting for children should be at least 2 h for clear water, 4 h for breast milk, 6 h for non-human or cow milk, 8 h for meat or oily food. It has been validated that 2 h fasting for clear water intake is safe in children, and it significantly reduces the thirst and hunger of sick children while waiting for the surgery [34]. In our institute, we try to calculate the precise timing of surgery and minimize the fasting time for children.

Most of the orthopaedic procedure does not need the drainage tube [35]; however, it is recommended in the DDH patients as the wounds are covered in Spica cast, and there is always the possibility of blood loss from the osteotomy sites causing postoperative hematoma and infection. In routine ERAS program, all kinds of catheters and drainage tubes are encouraged to remove early to promote early rehabilitation.

Early diet is recommended for DDH patients after anaesthesia awareness. However, most young children are not able to eat regular diet immediately after surgery. Noodles or thin soup was recommended for young children on the first meal postoperatively. Food rich in dietary fiber is recommended for the patient to lower the incidence of constipation. Walking is not possible postoperatively as the hips are immobilized in Spica cast. But early ambulation is always encouraged.

Fever was less in the ERAS group,possibly due to better temperature monitoring and management in the operating room. No patient had postoperative urinary tract infection because of early removal.

So far, there are limited reports of the ERAS program in the field of pediatric orthopaedics, most of our core components in the ERAS protocol were derivatives from research in adults. In clinical practice, the application of multimodal analgesia alleviates the postoperative pain response that increases the surgical cost. The predictive increase of medication cost might be compensated by the reduction of hospital stay; however, that requires multicenter study.

Several limitations exist in our study. First and foremost, it has all the biases of a retrospective study, and a prospective randomized control trial might be more convincing. Secondly, the follow-up was not long enough to validate the findings. Thirdly, there might be a surgeon’s bias as different surgeons of the same team performed all the surgeries; the outcome might be varied as per the surgeon’s experience.

Conclusion

The ERAS protocol is both safe and feasible choice for pediatric DDH patients undergoing osteotomies, and it shortens the duration of hospital stay. Continuous education and training should be given to the ERAS team, including the surgeon, nurses, anesthesiologist, caregiver, pediatrician to implement the protocols more strictly. Long-term follow up is required to validate the benefits of ERAS application in pediatric orthopaedics.

Availability of data and materials

This is a report of comparative study. To protect privacy and respect confidentiality, no raw data have been made available in any public repository. The operation reports, imaging studies are all retained as per normal procedure within the medical records of our institution.

Abbreviations

ERAS:

Enhanced recovery after surgery

MIS:

Minimal invasive surgery

DCT:

Damage control theory

POD:

Postoperative day

PONV:

Postoperative nausea and vomiting

VAS:

Visual analog scale

DDH:

Developmental dysplasia of the hip

PO:

Pelvic osteotomy

PFO:

Proximal femoral osteotomy

References

  1. 1.

    Kehlet H, Dahl JB. Anaesthesia, surgery and challenges in postoperative recovery [J]. Lancet. 2003;362(9399):1921–8.

    Article  Google Scholar 

  2. 2.

    Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation [J]. Br J Anaesth. 1997;78(5):606–17.

    CAS  Article  Google Scholar 

  3. 3.

    Wilmore DW, Kehlet H. Management of patients in fast tract surgery [J]. BMJ. 2001;322(7284):473–6.

    CAS  Article  Google Scholar 

  4. 4.

    Kehlet H. Fast-track hip and knee arthroplasty [J]. Lancet. 2013;381(9878):1600–2.

    Article  Google Scholar 

  5. 5.

    Lamplot JD, Wagner ER, Manning DW. Multimodal pain management in total knee arthroplasty: a prospective randomized controlled trial [J]. J Arthroplast. 2013;29(2):329–34.

    Article  Google Scholar 

  6. 6.

    Khan SK, Malviya A, Muller SD, et al. Reduced short-term complications and mortality following enhanced recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures [J]. Acta Orthop. 2014;85(1):26–31.

    Article  Google Scholar 

  7. 7.

    Hu ZC, He LJ, Chen D, et al. An enhanced recovery after surgery program in orthopedic surgery: a systematic review and meta-analysis [J]. J Orthop Surg Res. 2019;14(1):77.

    Article  Google Scholar 

  8. 8.

    Davies SJ, Walker G. Problems in the early recognition of hip dysplasia [J]. J Bone Joint Surg Br. 1984;66(4):479–84.

    CAS  Article  Google Scholar 

  9. 9.

    Gulati V, Eseonu K, Sayani J, et al. Developmental dysplasia of the hip in the newborn: a systematic review [J]. World J Orthop. 2013;4(2):32–41.

    Article  Google Scholar 

  10. 10.

    Farr S, Grill F, Müller D. When is the optimal time for hip ultrasound screening? Orthopade. 2008;37(6):532, 534-6, 538-40.

  11. 11.

    Bolland BJ, Wahed A, Al-Hallao S, et al. Late reduction in congenital dislocation of the hip and the need for secondary surgery: radiologic predictors and confounding variables [J]. J Pediatr Orthop. 2010;30:676–82.

    Article  Google Scholar 

  12. 12.

    Shorter D, Hong T, Osborn DA. Screening programmes for developmental dysplasia of the hip in newborn infants. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD004595.

  13. 13.

    Alves C, Truong WH, Thompson MV, et al. Diagnostic and treatment preferences for developmental dysplasia of the hip: a survey of EPOS and POSNA members. J Child Orthop. 2018;12:236–44.

    CAS  Article  Google Scholar 

  14. 14.

    Wang CW, Wang TM, Wu KW, et al. The comparative, long-term effect of the salter osteotomy and Pemberton acetabuloplasty on pelvic height, scoliosis and functional outcome [J]. Bone Joint J. 2016;98-B(8):1145–50.

    Article  Google Scholar 

  15. 15.

    Luo Y, Wang L, Chen M, et al. Salter and Pemberton osteotomy for the treatment of developmental hip dysplasia [J]. Mod Instrum Med. 2017;23(4):21–3.

    Google Scholar 

  16. 16.

    Hong P, Ze RH, Tang X, et al. Application and prospect of enhanced recovery after surgery in pediatric orthopedics [J]. J Clin Ped Sur. 2019;18(12):1072–7.

    Google Scholar 

  17. 17.

    Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011;114:495–511.

  18. 18.

    López-Carreño E, Carillo H, Gutiérrez M. Dega versus salter osteotomy for the treatment of developmental dysplasia of the hip. J Pediatr Orthop B. 2008;17(5):213–21.

    Article  Google Scholar 

  19. 19.

    Moraleda L, Bravo C, Forriol F, Albiñana J. Does orientation of the femoral head affect acetabular development? An experimental study in lamb. J Pediatr Orthop. 2017;1.

  20. 20.

    Blockey NJ. Derotation osteotomy in the management of congenital dislocation of the hip. J Bone Joint Surg (Br). 1984;66(4):485–90.

    CAS  Article  Google Scholar 

  21. 21.

    Wang MY, Chang PY, Grossman J. Development of an enhanced recovery after surgery (ERAS) approach for lumbar spinal fusion [J]. J Neurosurg Spine. 2017;26(4):411–8.

    Article  Google Scholar 

  22. 22.

    Mcdonald DA, Siegmeth R, Deakin AH, et al. An enhanced recovery programme for primary total knee arthroplasty in the United Kingdom-follow up at one year [J]. Knee. 2012;19(5):525–9.

    CAS  Article  Google Scholar 

  23. 23.

    Talboys R, Mak M, Modi N, et al. Enhanced recovery programme reduces opiate consumption in hip hemiarthroplasty [J]. Eur J Orthop Surg Traumatol. 2016;26(2):177–81.

    Article  Google Scholar 

  24. 24.

    Beattie WS, Karkouti K, Wijeysundera DN, et al. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study [J]. Anesthesiology. 2009;110(3):574–81.

    Article  Google Scholar 

  25. 25.

    Berend KR, Lombardi AV, Mallory TH. Rapid recovery protocol for perioperative care of total hip and total knee arthroplasty patients [J]. Surg Technol Int. 2004;13(2):239–47.

    PubMed  Google Scholar 

  26. 26.

    Kearney M, Jennrich MK, Lyons S, et al. Effects of preoperative education on patient outcomes after joint replacement surgery [J]. Ortho Nurs. 2011;30(6):391–6.

    Article  Google Scholar 

  27. 27.

    Chalmers DJ, Bielsky A, Wild TT, et al. Continuous local anesthetic infusion for children with spina bifida undergoing major reconstruction of the lower urinary tract [J]. J Pediatr Urol. 2015;11(2):e1–5.

    Article  Google Scholar 

  28. 28.

    Mont MA, Beaver WB, Dysart SH, et al. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trials [J]. J Arthroplast. 2018;33(1):90–6.

    Article  Google Scholar 

  29. 29.

    Backes JR, Bentley JC, Politi JR, et al. Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trails [J]. J Arthroplast. 2013;28(8 suppl):11–7.

    Article  Google Scholar 

  30. 30.

    De Oliveira GS, Almeida MD, Benzon HT, et al. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials [J]. Anesthesiology. 2011;115(3):575–88.

    Article  Google Scholar 

  31. 31.

    Saleh AH, Hassan PF, Elayashy M, et al. Role of dexamethasone in the para-vertebral block for pediatric patients undergoing aortic coarctation repair. randomized, double-blinded controlled study. BMC Anesthesiol. 2018;18(1):178.

    CAS  Article  Google Scholar 

  32. 32.

    Abd-Elshafy SK, Yacoup AM, Abdalla EE, et al. A new look on adding dexamethasone as an adjuvant to caudal bupivacaine; efficacy on postoperative pain and vomiting in pediatric patients. Pain Physician. 2016 Jul;19(6):E841–52.

    PubMed  Google Scholar 

  33. 33.

    Brady M, Kinn S, Ness V, et al. Preoperative fasting for preventing perioperative complications in children [J]. Cochrane Database Syst Rev. 2009;7(4):CD005285.

    Google Scholar 

  34. 34.

    Reynolds RA, Jackson H. Concept of treatment in supracondylar humeral fractures [J]. Injury. 2004;12(013).

  35. 35.

    Frye BD, Hannon P, Santoni BG, et al. Drains are not beneficial in primary shoulder arthroplasty [J]. Orthopedics. 2019;42(1):e29–31.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

None.

Author information

Affiliations

Authors

Contributions

PH* is in charge of the main idea and is the guarantor of integrity of the entire clinical study; JL and RHZ are in charge of the study concepts, design, manuscript preparation and editing; PH and SR are in charge of the language polishing and the grammar revision; RKL and XT is in charge of the collection of the study data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Pan Hong.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written consents were obtained from the patients for publication of this paper.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, J., Rai, S., Ze, R. et al. Enhanced recovery care versus traditional non-ERAS care following osteotomies in developmental dysplasia of the hip in children: a retrospective case-cohort study. BMC Musculoskelet Disord 21, 234 (2020). https://doi.org/10.1186/s12891-020-03243-z

Download citation

Keywords

  • Enhanced recovery after surgery
  • Developmental dysplasia of the hip
  • Complications
  • Hospitalization
  • Osteotomy
\